Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa
Clinical trials sponsored by Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa, explained in plain language.
-
New COPD inhaler shows promise in Short-Term lung function test
Disease control CompletedThis study tested three different doses of an inhaled medication called glycopyrrolate in 46 adults with COPD. Participants used the drug twice daily for one week to see if it improved their lung function compared to a placebo. The goal was to find out how well it works and if it…
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated May 26, 2026 07:10 UTC
-
New COPD combo inhaler shows promise in early trial
Disease control CompletedThis study tested a new inhaled drug combination (ensifentrine and glycopyrrolate) in 33 adults with COPD. The goal was to see how the drug moves through the body, how well it helps breathing, and if it is safe. Participants received single doses of the combination and each drug …
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated May 26, 2026 06:52 UTC